Atlas Trials

Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC

Clinical trial NCT00801801 · TERMINATED

Trial details

NCT number
NCT00801801
Sponsor
Francisco Robert,MD
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Non Squamous Cell Lung CancerNon Small Cell Lung Cancer
Start date
2008-01-01
Primary completion
2009-10-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.